Inactive Instrument
Deltagen Inc. Share Price Other OTC
Stocks
DGEN
US24783R1032
Pharmaceuticals
OTC Markets Traded
| Market Cap | 4.71M 4.08M 3.77M 3.53M 6.59M 451M 6.73M 44.91M 17.39M 217M 17.67M 17.29M 755M | P/E Ratio 2005 * |
-
| P/E Ratio 2006 | 4.04x |
|---|---|---|---|---|---|
| Enterprise Value | -1.43M -1.24M -1.14M -1.07M -2M -137M -2.04M -13.63M -5.28M -65.92M -5.36M -5.25M -229M | EV / Sales 2005 * |
-
| EV / Sales 2006 | 1.16x |
| Free-Float |
100% | Yield 2005 * |
-
| Yield 2006 | - |
| 1 day | +154.90% |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Driscoll
CEO | Chief Executive Officer | - | 31/12/2004 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +154.90% | +154.90% | - | - | 32 | |
| +1.46% | -0.51% | -38.18% | -54.88% | 2.26B | |
| -0.46% | -9.63% | -60.18% | -88.43% | 1.6B | |
| +1.91% | +0.84% | -8.03% | -11.74% | 314M | |
| +4.82% | -1.40% | -38.25% | - | 56.72M | |
| Average | +32.61% | -0.30% | -36.16% | -51.68% | 1.06B | |
| Weighted average by Cap. | +1.03% | -1.09% | -44.25% | -64.47% |
| 2002 | 2003 * | |
|---|---|---|
| Net sales | 17.69M 15.35M 14.15M 13.26M 24.77M 1.69B 25.29M 169M 65.35M 816M 66.41M 64.98M 2.84B | - |
| Net income | -107M -93M -85.73M -80.33M -150M -10.26B -153M -1.02B -396M -4.95B -402M -394M -17.2B | - |
| Net Debt | 1.75M 1.52M 1.4M 1.31M 2.45M 167M 2.5M 16.67M 6.45M 80.63M 6.56M 6.42M 280M | - |
Employees
-
Sector
Pharmaceuticals
